Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Idexx Laboratories Norge AS
AS
Active
Org 997712196
Wergelandsveien 7, 0167
Oslo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2011 · 14 years old
10 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Idexx Laboratories Norge AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
128M
96M
64M
32M
0M
2020: 87M
87M
2020
2021: 103M (+18% vs 2020)
103M
+18%
2021
2022: 13M (-87% vs 2021)
13M
-87%
2022
2023: 14M (+8% vs 2022)
14M
+8%
2023
2024: 17M (+21% vs 2023)
17M
+21%
2024
EBITDA
NOK millions
5M
4M
2M
1M
0M
2020: 2M
2M
2020
2021: 2M (0% vs 2020)
2M
0%
2021
2022: 2M (0% vs 2021)
2M
0%
2022
2023: 3M (+50% vs 2022)
3M
+50%
2023
2024: 4M (+33% vs 2023)
4M
+33%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
16 587
14 077
12 925
102 548
87 258
Staff expenses
−8 369
−6 641
−6 219
−4 486
−0
EBITDA
3 928
2 859
2 439
2 064
2 177
Depreciation & amort.
−49
−84
−214
−376
−489
EBIT
3 879
2 776
2 225
1 688
1 688
Net financials
−28
15
−16
7
−20
Profit before tax
3 852
2 791
2 209
1 695
1 669
Tax
858
629
496
378
371
Net profit
2 994
2 162
1 713
1 318
1 298
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
39 985
31 259
24 891
29 521
26 206
Equity
17 817
14 823
12 661
10 948
9 630
Long-term debt
0
681
738
786
867
Short-term debt
21 549
15 755
11 492
17 787
15 709
Total debt
21 549
16 436
12 231
18 573
16 576
Financial ratios
5-year trend
EBITDA margin
23,7 %
This company
15,8 %
Market median
This company
Market median
50% above market
2020
2024
Equity ratio
44,6 %
This company
38,2 %
Market median
This company
Market median
17% above market
2020
2024
Return on equity
16,8 %
This company
18,4 %
Market median
This company
Market median
9% below market
2020
2024
Net profit margin
18,0 %
This company
8,1 %
Market median
This company
Market median
122% above market
2020
2024
Asset turnover
0,41×
This company
1,12×
Market median
This company
Market median
63% below market
2020
2024
Debt / equity
1,24×
This company
0,62×
Market median
This company
Market median
100% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Idexx Laboratories Norge AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
